[Translated article] RF – Potential Treatments for Monkeypox

Hospital‐based salient prevention and control measures to counteract the 2022 monkeypox outbreak

“…Supportive care comprising of symptomatic treatment, rehydration to lessen fluid losses, hemodynamic and oxygen balance, and checking bacterial coinfections with lubricants, antibiotics, and antivirals play crucial role in managing mpox affected patients 8,9 . Tecovirimat, brincidofovir, and cidofovir, and vaccinia immune globulin intravenous have been suggested for treating serious cases of mpox patients 4,8–11 . The CDC recommends a protocol that allows for the use of tecovirimat for primary or early empiric treatment of non‐variola orthopoxvirus infections, including mpox, in adults and children of all ages.…”

“…8,9 Tecovirimat, brincidofovir, and cidofovir, and vaccinia immune globulin intravenous have been suggested for treating serious cases of mpox patients. 4,[8][9][10][11] The CDC recommends a protocol that allows for the use of tecovirimat for primary or early empiric treatment of non-variola orthopoxvirus infections, including mpox, in adults and children of all ages. Vaccination of frontline health workers, medical and laboratory staff need to be done as these mainly comes in contact with MPXV infected patients and are at greatest risk to be infected.…”